Advancements in Osteochondritis Care: The ROCK Research Study Group Wins IMPACT Award

On March 4, 2026, during the prestigious AAOS annual meeting in New Orleans, the 2026 Improving Musculoskeletal Patient Care Through Outcomes Research (IMPACT) Award was presented to Dr. Kevin Shea and the Research in Osteochondritis of the Knee (ROCK) Research Study Group. This award recognizes their significant contributions over a remarkable 15-year period in developing advanced strategies for addressing knee osteochondritis dissecans (OCD).

Osteochondritis dissecans predominantly affects adolescents and, if left unchecked, can lead to early-onset osteoarthritis. The lack of substantial research data has often hindered medical professionals from making informed decisions regarding treatment options. The groundbreaking work of the ROCK Research Study Group changes this narrative, providing deeper insights into the causes, clinical manifestations, imaging characteristics, and treatment approaches for OCD.

Dr. Shea, the lead researcher and an esteemed orthopaedic surgeon at Stanford University, noted the particular vulnerability of young athletes to OCD. He commented, "The impact of knee OCD often reverberates beyond physical health; it can have substantial psychosocial implications, especially when young athletes have to step back from their active lifestyles. If left untreated, we see a significant rise in the chances of developing osteoarthritis within a decade and a half. Our mission is to ensure that individuals retain their joint function and continue to enjoy physical activities throughout their lives."

The establishment of ROCK was prompted by Dr. Shea's collaboration with leading doctors such as Theodore Ganley, MD, and Eric Wall, MD, alongside a talented team comprising surgeons, physical therapists, and radiologists. Today, ROCK has transformed into a global research consortium that boasts over 70 active members who are actively exploring a vast range of more than 100 research questions related to knee OCD.

Since its inception, ROCK has orchestrated the enrollment of over 1,900 patients from 25 academic centers, resulting in the publication of numerous articles focusing on the etiology and treatment pathways associated with knee OCD. A significant highlight from their research includes the development of a reliable classification system for diagnosing the severity of OCD—a breakthrough achieved by examining 300 arthroscopy videos and implementing a sophisticated six-category arthroscopic classification method.

Further, ROCK has focused on identifying predictors for healing through prospective cohort studies. By employing innovative machine learning algorithms, researchers have built models that consider variables like age, sex, and lesion stability to better forecast which OCD cases might heal without surgical intervention. Notably, location of the lesion in relation to the condyle emerged as a critical factor influencing the likelihood of nonoperative treatment success.

Dr. Shea emphasizes the urgent need for these tools, stating, "Over 50% of those affected by knee OCD do not recover through nonoperative means and require surgical intervention. The insights provided by these predictive algorithms equip families with data-driven estimates regarding healing potential, enabling more informed decisions alongside their care teams."

ROCK's commitment to optimizing treatment methodologies is also reflected in ongoing research, including random controlled trials aimed at determining the most effective surgical interventions for OCD. Two drilling techniques, trans-articular and retro-articular methods, are currently under scrutiny, focusing on their efficacy in promoting blood flow in the bone surrounding OCD lesions.

Looking ahead, ROCK is leveraging advanced AI technology to refine patient care protocols further. Their vision includes creating tools that not only analyze various imaging studies but actively inform treatment strategies tailored to individual patients. The integration of biological stimulants, such as growth factors and stem cell therapies, into rehabilitation practices is also on the horizon.

The American Academy of Orthopaedic Surgeons (AAOS), representing the largest community of musculoskeletal health professionals globally, plays a pivotal role in supporting initiatives such as ROCK. By investing in education and research, the AAOS aims to advance best practices and improve the quality of care for patients. Dr. Shea's work, together with the ROCK team's innovative approach, exemplifies the type of impactful research necessary to enhance outcomes for those battling knee osteochondritis dissecans, ultimately fostering a healthier future for young athletes and beyond.

Follow the AAOS on social media platforms for more updates and information about musculoskeletal health advancements.